02171.HK
CARsgen Therapeutics Holdings Limited
HKSE · Healthcare · Biotechnology · CN
HKD 10.95
−2.67%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -1.21x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.38x
- Net debt / EBITDA
- 6.93x
Liquidity & coverage
- Current ratio
- 7.07x
- Quick ratio
- 7.04x
- Cash ratio
- 6.79x
- Interest coverage
- -12.49x
- EBITDA / interest
- -24.18x
- Working capital
- HKD 1.5B
Cash & dividend
- FCF / debt
- -2.59x
- Cash flow / debt
- -2.43x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026